Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rouleau

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
HIV Medicine|January 27, 2012
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical studyJ P Routy, C L Tremblay, J B Angel, et al.
AIDS (London, England)|March 9, 2000
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection StudyH Salomon, M A Wainberg, B Brenner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infectionG Alter, G Hatzakis, C M Tsoukas, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
HIV Medicine|September 1, 2007
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administrationM R Loutfy, M Harris, J M Raboud, et al.
HIV Medicine|May 30, 2012
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortalityM B Klein, K C Rollet, S Saeed, et al.
Nature Microbiology|August 11, 2025
FungAMR: a comprehensive database for investigating fungal mutations associated with antimicrobial resistanceCamille Bédard, Alicia Pageau, Anna Fijarczyk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2015
Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell CountsWei Cao, Vikram Mehraj, Benoit Trottier, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
HIV Medicine|January 27, 2012
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical studyJ P Routy, C L Tremblay, J B Angel, et al.
AIDS (London, England)|March 9, 2000
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection StudyH Salomon, M A Wainberg, B Brenner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infectionG Alter, G Hatzakis, C M Tsoukas, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
HIV Medicine|September 1, 2007
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administrationM R Loutfy, M Harris, J M Raboud, et al.
HIV Medicine|May 30, 2012
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortalityM B Klein, K C Rollet, S Saeed, et al.
Nature Microbiology|August 11, 2025
FungAMR: a comprehensive database for investigating fungal mutations associated with antimicrobial resistanceCamille Bédard, Alicia Pageau, Anna Fijarczyk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2015
Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell CountsWei Cao, Vikram Mehraj, Benoit Trottier, et al.
Pageof 5